特利加压素-话题@MedSci

#特利加压素#

10篇内容 | 1395人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2180430, encodeId=2bd321804300c, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a> <a href='/topic/show?id=c8bf109e95ca' target=_blank style='color:#2F92EE;'>#肝硬化静脉曲张出血#</a>, objectTitle=APT：肝硬化静脉曲张出血患者静脉注射特利加压素1天与3天的比较, objectType=article, longId=808711, objectId=8b10808e114b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301015/1697393424174_4754896.jpeg, objectUrl=/article/show_article.do?id=8b10808e114b, replyNumber=0, likeNumber=61, createdTime=2024-01-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8b10808e114b, moduleTitle=APT：肝硬化静脉曲张出血患者静脉注射特利加压素1天与3天的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b10808e114b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1736857, encodeId=f1761e368579e, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=权威发布｜特利加压素在肝硬化并发症临床应用的实践指导(2021版), objectType=article, longId=738999, objectId=0694e3899931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0694e3899931, replyNumber=0, likeNumber=97, createdTime=2023-01-20, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0694e3899931, moduleTitle=权威发布｜特利加压素在肝硬化并发症临床应用的实践指导(2021版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0694e3899931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2092808, encodeId=b6322092808de, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准的<a href='/topic/show?id=60c232154fc' target=_blank style='color:#2F92EE;'>#创新药物#</a>，这里看到常见病，如<a href='/topic/show?id=91cf549e3f1' target=_blank style='color:#2F92EE;'>#抑郁症#</a>，<a href='/topic/show?id=13032e051f7' target=_blank style='color:#2F92EE;'>#便秘#</a>的治疗，也有<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a>，如<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>的<a href='/topic/show?id=567041e8055' target=_blank style='color:#2F92EE;'>#基因治疗#</a>上市。还有<a href='/topic/show?id=0eca955681e' target=_blank style='color:#2F92EE;'>#酶替代治疗#</a><a href='/topic/show?id=e6b910492475' target=_blank style='color:#2F92EE;'>#Xenpozyme#</a>，<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>治疗成人<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a> (HRS)等，整体来说，创新药呈现是加速发展的趋势。, objectTitle=FDA在2022年第三季度批准了哪些创新药（下）？, objectType=article, longId=742666, objectId=b6c8e42666e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20221009/ab2e59afdf774f8881a31e168706d9f7.jpg, objectUrl=/article/show_article.do?id=b6c8e42666e2, replyNumber=0, likeNumber=190, createdTime=2022-10-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6c8e42666e2, moduleTitle=FDA在2022年第三季度批准了哪些创新药（下）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6c8e42666e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736855, encodeId=8b8b1e36855fc, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, objectType=article, longId=208183, objectId=5b2d208183e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b2d208183e4, replyNumber=0, likeNumber=89, createdTime=2021-08-03, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b2d208183e4, moduleTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b2d208183e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736856, encodeId=96f11e3685635, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, objectType=article, longId=211429, objectId=be23211429df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be23211429df, replyNumber=0, likeNumber=80, createdTime=2021-09-07, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be23211429df, moduleTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be23211429df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736853, encodeId=c4751e36853a9, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=特利加压素治疗1型肝肾综合症：获得FDA咨询委员会的投票支持, objectType=article, longId=197639, objectId=2d3819e639a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d3819e639a3, replyNumber=0, likeNumber=78, createdTime=2021-04-22, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d3819e639a3, moduleTitle=特利加压素治疗1型肝肾综合症：获得FDA咨询委员会的投票支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d3819e639a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736854, encodeId=36971e36854b1, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率, objectType=article, longId=204222, objectId=abb0204222a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abb0204222a7, replyNumber=0, likeNumber=104, createdTime=2021-02-11, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abb0204222a7, moduleTitle=Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abb0204222a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736852, encodeId=b8861e36852a4, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=Mallinckrodt的特利加压素达到1型肝肾综合症III期研究的主要目标, objectType=article, longId=177803, objectId=fbaf1e78035c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbaf1e78035c, replyNumber=0, likeNumber=94, createdTime=2019-12-09, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbaf1e78035c, moduleTitle=Mallinckrodt的特利加压素达到1型肝肾综合症III期研究的主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbaf1e78035c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736851, encodeId=53a11e36851c9, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=【临床重症】特利加压素？去甲肾上腺素？亦或都用在脓毒性休克中？, objectType=article, longId=161670, objectId=792d1616e0fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=792d1616e0fd, replyNumber=0, likeNumber=83, createdTime=2019-06-08, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=792d1616e0fd, moduleTitle=【临床重症】特利加压素？去甲肾上腺素？亦或都用在脓毒性休克中？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=792d1616e0fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736850, encodeId=32f21e368506c, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=Intens Care Med：脓毒性休克患者输注特利加压素与去甲肾上腺素的疗效比较！, objectType=article, longId=142973, objectId=195e1429e38e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195e1429e38e, replyNumber=0, likeNumber=104, createdTime=2018-12-06, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195e1429e38e, moduleTitle=Intens Care Med：脓毒性休克患者输注特利加压素与去甲肾上腺素的疗效比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=195e1429e38e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1736849, encodeId=af661e36849d9, content=<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>, objectTitle=Aliment Pharmacol Ther：肝肾综合征1型：特利加压素+白蛋白vs安慰剂+白蛋白, objectType=article, longId=103153, objectId=130710315300, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=130710315300, replyNumber=0, likeNumber=104, createdTime=2017-11-18, rootId=0, userName=sunrural_42825368, userId=5cfa34187329, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=130710315300, moduleTitle=Aliment Pharmacol Ther：肝肾综合征1型：特利加压素+白蛋白vs安慰剂+白蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=130710315300)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

特利加压素

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#特利加压素# #肝硬化静脉曲张出血#

APT：肝硬化静脉曲张出血患者静脉注射特利加压素1天与3天的比较

2024-01-10发表于上海

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

权威发布｜特利加压素在肝硬化并发症临床应用的实践指导(2021版)

2023-01-20

lifestar (审核中...)

前往app查看评论内容

#FDA#批准的#创新药物#，这里看到常见病，如#抑郁症#，#便秘#的治疗，也有#罕见病#，如#β地中海贫血#的#基因治疗#上市。还有#酶替代治疗##Xenpozyme#，#特利加压素#治疗成人#肝肾综合征# (HRS)等，整体来说，创新药呈现是加速发展的趋势。

FDA在2022年第三季度批准了哪些创新药（下）？

2022-10-10

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

NEJM：特利加压素联合白蛋白治疗1型肝肾综合征

2021-08-03

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关

2021-09-07

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

特利加压素治疗1型肝肾综合症：获得FDA咨询委员会的投票支持

2021-04-22

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

Hepatology：特利加压素可较去甲肾上腺素给予更好的改善ACLF患者的生存率

2021-02-11

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

Mallinckrodt的特利加压素达到1型肝肾综合症III期研究的主要目标

2019-12-09

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

【临床重症】特利加压素？去甲肾上腺素？亦或都用在脓毒性休克中？

2019-06-08

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

Intens Care Med：脓毒性休克患者输注特利加压素与去甲肾上腺素的疗效比较！

2018-12-06

sunrural_42825368 (审核中...)

前往app查看评论内容

#特利加压素#

Aliment Pharmacol Ther：肝肾综合征1型：特利加压素+白蛋白vs安慰剂+白蛋白

2017-11-18

科室
- - 订阅+
  - 更多科室
工具
服务